|
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 |
SCHEDULE 13G
|
UNDER THE SECURITIES EXCHANGE ACT OF 1934
|
(Amendment No. 1)*
|
Oncology Institute, Inc. (Name of Issuer) |
Common Stock, $0.0001 Par Value Per Share (Title of Class of Securities) |
(CUSIP Number) |
03/13/2026 (Date of Event Which Requires Filing of this Statement) |
| Check the appropriate box to designate the rule pursuant to which this Schedule is filed: |
 Rule 13d-1(b)
|
 Rule 13d-1(c)
|
| Rule 13d-1(d)
|
SCHEDULE 13G
|
| CUSIP No. |
| 1 | Names of Reporting Persons
Chernett Jorey | ||||||||
| 2 | Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
| ||||||||
| 3 | Sec Use Only | ||||||||
| 4 | Citizenship or Place of Organization
UNITED STATES
| ||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
| 9 | Aggregate Amount Beneficially Owned by Each Reporting Person
10,115,944.00 | ||||||||
| 10 | Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
| ||||||||
| 11 | Percent of class represented by amount in row (9)
10.2 % | ||||||||
| 12 | Type of Reporting Person (See Instructions)
IN |
SCHEDULE 13G
|
| Item 1. | |
| (a) | Name of issuer:
Oncology Institute, Inc. |
| (b) | Address of issuer's principal executive offices:
18000 Studebaker Rd., Ste. 800, CERRITOS, CALIFORNIA, 90703. |
| Item 2. | |
| (a) | Name of person filing:
Jorey Chernett (the "Reporting Person") |
| (b) | Address or principal business office or, if none, residence:
The principal business address of the Reporting Person is 6222 Indianwood Trail, Bloomfield Hills, MI 48301. |
| (c) | Citizenship:
US. |
| (d) | Title of class of securities:
Common Stock, $0.0001 Par Value Per Share |
| (e) | CUSIP No.:
|
| Item 4. | Ownership |
| (a) | Amount beneficially owned:
As of the close of business on March 13, 2026, the Reporting Person beneficially owned 10,115,944 shares of Common stock, par value $0.0001 per share, of the Issuer (the "Shares"). |
| (b) | Percent of class:
The aggregate percentage of Shares owned by the Reporting Person is based upon 98,839,144 Shares outstanding as of March 5, 2026, as disclosed in the Issuer's Annual Report on Form 10-K, filed with the U.S. Securities and Exchange Commission on March 12, 2026.
As of the close of business on March 13, 2026, the Reporting Person may be deemed to beneficially own 10.23% of the outstanding Shares. %
|
| (c) | Number of shares as to which the person has:
|
| (i) Sole power to vote or to direct the vote:
See Cover Pages Items 5-9. | |
| (ii) Shared power to vote or to direct the vote:
See Cover Pages Items 5-9. | |
| (iii) Sole power to dispose or to direct the disposition of:
See Cover Pages Items 5-9. | |
| (iv) Shared power to dispose or to direct the disposition of:
See Cover Pages Items 5-9. | |
| Item 5. | Ownership of 5 Percent or Less of a Class. |
| Item 6. | Ownership of more than 5 Percent on Behalf of Another Person. |
Not Applicable
| |
| Item 7. | Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person. |
Not Applicable
| |
| Item 8. | Identification and Classification of Members of the Group. |
Not Applicable
| |
| Item 9. | Notice of Dissolution of Group. |
Not Applicable
|
| Item 10. | Certifications: |
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.
|
| SIGNATURE | |
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
|
|
|